Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Telemedicine Is Riding High, Hopes For More Provisions In 'Phase Three' COVID-19 Stimulus Package

Executive Summary

The nation's leading telehealth advocate group expects CMS will provide additional support for telemedicine to help curb the spread of COVID-19.

You may also be interested in...



Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis

In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.

Exec Chat: Boston Scientific’s Angelo De Rosa Forsees Digital Transformation In The COVID-19 Era

Angelo De Rosa, VP of Boston Scientific's cardiac rhythm management business in Europe, the Middle East and Africa, talked to Medtech Insight about the opportunities to accelerate digital transformation in health care during the COVID-19 crisis.

Beyond COVID-19: Industry Insiders Offer 10 Strategies For Medtech Recovery

Medtech insiders offer 10 strategies for medtech companies to rethink their businesses right now.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel